Valley Wealth Managers, Inc.
Source: SEC Form 13F · as of Mar 2026Valley Wealth Managers, Inc. holds 18 biotech & pharma companies tracked by BioSniper, totaling $123.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$123.2M
| Company | Shares | Value |
|---|---|---|
| PFEPFIZER INC | 948,832 | $26.6M |
| AMGNAMGEN INC | 69,051 | $24.3M |
| CORCencora Inc. | 77,025 | $24.2M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 50,139 | $22.4M |
| ABBVAbbVie Inc. | 26,564 | $5.8M |
| MRKMerck & Co., Inc. | 47,344 | $5.7M |
| GILDGILEAD SCIENCES, INC. | 35,962 | $5.0M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 16,852 | $4.6M |
| LLYELI LILLY & Co | 3,664 | $3.4M |
| JNJJOHNSON & JOHNSON | 3,125 | $764K |
| ABTABBOTT LABORATORIES | 902 | $93K |
| PMPhilip Morris International Inc | 525 | $87K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 1,508 | $83K |
| ZTSZoetis Inc. | 670 | $79K |
| AZNASTRAZENECA PLC | 374 | $74K |
| NVSNovartis AG | 453 | $69K |
| XTNTXtant Medical Holdings, Inc. | 298 | $166 |
| CRSPCRISPR Therapeutics AG | 0 | $11 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.